Injectable Nanoparticles Turn Off Drug Resistance While Pushing Meds Into Tumors - MedGadget

Description

A tumor’s developing drug resistance is driven in large part by its genome, which has mechanisms to protect cancer cells from chemical attacks and apoptosis. Researchers at MIT are using nanoparticles made out of gold specs surrounded by a hydrogel to turn off tumors’ ability to develop drug resistance by inactivating specific genes.